These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1857478

  • 21. [The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Tesutani T, Yamamoto M, Fujimoto Y, Okubo A, Oka G.
    Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):135-55. PubMed ID: 381736
    [No Abstract] [Full Text] [Related]

  • 22. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 23. Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis.
    First MR, Goldberg B, Abrahams C.
    S Afr Med J; 1972 Jun 17; 46(25):848-9. PubMed ID: 5076072
    [No Abstract] [Full Text] [Related]

  • 24. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
    Park Y, Jeong YH, Tantry US, Ahn JH, Kim KH, Koh JS, Park JR, Hwang SJ, Kwak CH, Hwang JY, Gurbel PA.
    Thromb Haemost; 2014 Dec 17; 112(6):1198-208. PubMed ID: 25182660
    [Abstract] [Full Text] [Related]

  • 25. [Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
    Ueda Y, Tojo S, Hatano M, Furukawa T, Yoshinaga K, Kinoshita Y, Takeuchi J, Kato E, Ohno J, Kobayashi K, Abe H, Omae S.
    Nihon Jinzo Gakkai Shi; 1979 Nov 17; 21(11):1171-83. PubMed ID: 396401
    [No Abstract] [Full Text] [Related]

  • 26. Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
    Izumino K, Iida H, Asaka M, Sasayama S.
    Nephron; 1987 Nov 17; 45(4):306-10. PubMed ID: 2953980
    [Abstract] [Full Text] [Related]

  • 27. [Attempt at heparin therapy for rapidly progressing idiopathic glomerulonephritis].
    Suc JM, Durand D, Conte J, Mignon-Conte M, Orfila C, Ton That HT, Duchet JP.
    J Urol Nephrol (Paris); 1975 Nov 17; 81(4-5):291-8. PubMed ID: 1159888
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Urinary protein reduction by anticoagulant and fibrinolytic therap- in membranous glomerulonephropathy].
    Kawaguchi N, Seki H, Furukawa K, Okuda S, Kimura I.
    Nihon Jinzo Gakkai Shi; 1977 Feb 17; 19(2):91-8. PubMed ID: 559831
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Meta-analysis of antiplatelet therapy for IgA nephropathy.
    Taji Y, Kuwahara T, Shikata S, Morimoto T.
    Clin Exp Nephrol; 2006 Dec 17; 10(4):268-73. PubMed ID: 17186331
    [Abstract] [Full Text] [Related]

  • 33. [Studies on antinephritic action of dipyridamole (1). The effect of dipyridamole on anti-GBM induced nephritis in rats (author's transl)].
    Suzuki Y, Ito M.
    Nihon Jinzo Gakkai Shi; 1981 Mar 17; 23(3):323-32. PubMed ID: 7311118
    [No Abstract] [Full Text] [Related]

  • 34. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E, PISA (Persantin In Stable Angina) study group.
    Eur Heart J; 2001 Oct 17; 22(19):1785-93. PubMed ID: 11549300
    [Abstract] [Full Text] [Related]

  • 35. [Use of curantyl in diffuse glomerulonephritis].
    Zorina SS, Orlova NN, Krasik IaD.
    Klin Med (Mosk); 1977 May 17; 55(5):122-6. PubMed ID: 875323
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment with platelet aggregation inhibitors in renal diseases].
    Nestor G.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976 May 17; 28(6):429-34. PubMed ID: 14380
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
    Knotková V, Petrů I, Nĕmecek K, Cieslar P, Pelèska J, Jáchymová M, Pick P, Tomasy M.
    Cas Lek Cesk; 1989 Jun 28; 128(26):814-8. PubMed ID: 2507156
    [Abstract] [Full Text] [Related]

  • 39. Effect of dipyridamole on myocardial reperfusion injury: A double-blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery.
    El Messaoudi S, Wouters CW, van Swieten HA, Pickkers P, Noyez L, Kievit PC, Abbink EJ, Rasing-Hoogveld A, Bouw TP, Peters JG, Coenen MJ, Donders AR, Riksen NP, Rongen GA.
    Clin Pharmacol Ther; 2016 Apr 28; 99(4):381-9. PubMed ID: 25773594
    [Abstract] [Full Text] [Related]

  • 40. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr 28; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.